IJE Software logoIJEsoft
ServicesPortfolioPricingAboutCase StudyStackNewsBlogPartnerPH NewsMarketsContactGet in touch
← Back to Philippines Business News
Manila Times Business

IBA Launches QUASAR® Penta-Guide Performance Phantom

More than 25 imaging and machine QA tests in one setup. Louvain-la-Neuve, Belgium, 27 September 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and quality assurance (QA) solutions, today announces the launch of the QUASAR®1 Penta-Guide Performance Phantom. Designed for modern radiotherapy workflows, the new phantom enables more than 25 imaging and machine QA tests to be performed in a single setup. By cons

Context & Analysis

For Philippine hospitals, the issue behind this announcement is the hidden infrastructure of cancer care. A linear accelerator can deliver precise radiation only if its imaging, motion control, and dose output are verified repeatedly. Quality assurance phantoms act as standardized test targets that let medical physicists check whether a machine behaves the way it should before treating patients. In practice, this matters because modern radiotherapy often relies on image-guided techniques, small fields, and complex treatment plans; small calibration drift can translate into clinical risk or wasted time.

In the Philippine context, where private oncology centers are expanding and public tertiary hospitals are under pressure to manage rising cancer burdens, reliable QA is a capacity issue as much as a technology issue. It affects throughput, service contracts, staff workload, and compliance with device registration, radiation safety, and accreditation expectations. When multiple checks are consolidated into a routine workflow, it may reduce the time physicists spend moving phantoms between tests, lower dependence on manual routines, and make it easier for smaller facilities to maintain consistent standards without a large bench of specialists. That is especially relevant in a market where imported equipment requires local installation support, calibration records, and ongoing technical service.

What to watch next is adoption rather than the product itself. Philippine buyers will likely care about whether the system integrates with existing accelerators, how it fits current QA schedules, what training is required for medical physicists and dosimetrists, and whether maintenance or consumables create recurring costs. Insurers, hospital administrators, and regulators may also look at whether streamlined QA helps standardize treatment quality across facilities. If the platform becomes part of routine practice, its value will show not in a launch announcement but in fewer machine interruptions, clearer audit trails, and more confidence that patients receive the intended dose.

Analysis by IJE Software — original commentary on the story above.

This is an excerpt. Read the full article at the original source:

Source: manilatimes.net

More from Manila Times Business

Bela Padilla confirms split from Martin Tan: ‘Loving someone also means knowing when to let go’

5h ago

Crypto News: Remittix Announces Official Listing Date as Solana Price Prediction Targets $1,000

5h ago

Two giant pandas sent by China arrive in US

5h ago

A'ja Wilson wins AP WNBA Player of the Year for 3rd straight year; Angel Reese top defensive player

6h ago

Your Daily Briefing

AI business companion — delivered every morning

Markets, PH news, financial insights, and devotionals — curated by AI and sent at 7 AM PHT. Pick your topics below.

Devotionals
Blog Topics
HR & Workforce
Real Estate & Property
News & Markets

1 topic selected